Coagulopathy in Beta-Thalassemia: Current Understanding and Future Perspectives
Author Information
Author(s): Cappellini M. Domenica, Musallam Khaled M., Marcon Alessia, Taher Ali T.
Primary Institution: Università Cattolica del Sacro Cuore
Hypothesis
What are the factors contributing to the hypercoagulable state in patients with thalassemia?
Conclusion
The study identifies diverse factors contributing to the hypercoagulable state in thalassemia, with a higher incidence of thrombotic events in thalassemia intermedia compared to thalassemia major.
Supporting Evidence
- Thromboembolic events occurred 4.38 times more frequently in thalassemia intermedia than in thalassemia major.
- Patients with thalassemia intermedia who developed a thromboembolic event were mostly splenectomized and had a hemoglobin level below 9 g/dl.
- Older age and transfusion naivety were associated with a higher incidence of thrombotic events.
Takeaway
Thalassemia patients can have blood that clots too easily, which can lead to serious problems like strokes. This happens more often in some types of thalassemia than others.
Methodology
This review summarizes current knowledge of the clinical and pathophysiological characteristics of hypercoagulability in thalassemia patients and highlights available strategies to prevent thromboembolic events.
Potential Biases
Potential bias due to the reliance on observational studies and the lack of randomized controlled trials.
Limitations
The available data on the use of anticoagulants and antiplatelet agents in thalassemia are either lacking or involve small, poorly controlled studies.
Participant Demographics
The study analyzed data from 8860 thalassemia patients, including 6670 with thalassemia major and 2190 with thalassemia intermedia.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website